Phase 4
Completed N=50
Post-Op Lidocaine Patch
Pain, Postoperative
Source: ClinicalTrials.gov NCT03500211 ↗
Enrolled (actual)
50
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcomePrimary: 12-hour Postoperative Pain Scores — 33.5; 28.8 score on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Randomized control trial evaluating use of lidocaine vs placebo patch for post-operative cesarean incision pain.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY 12-hour Postoperative Pain Scores |
33.5; 28.8 | — |
| PRIMARY 24-hour Postoperative Pain Scores |
34.1; 32.9 | — |
| PRIMARY 36-hour Postoperative Pain Scores |
37.3; 43.0 | — |
| PRIMARY 48-hour Postoperative Pain Scores |
24.8; 29.6 | — |
| SECONDARY 5-days Postoperative Narcotic Use |
8.6; 8.3 | — |
Eligibility Criteria
Inclusion Criteria
- Pregnant patients who require a scheduled or non-urgent cesarean birth
- Patient able to receive neuraxial analgesia
- Patient able to give verbal and written consent for both cesarean birth and study
Exclusion Criteria
- Patients requiring emergent cesarean birth
- Patients allergic to lidocaine or adhesive
- Patients who have already received an epidural during this admission or requiring general anesthesia for cesarean birth
- Patients using chronic oral neuromodulators
- Patients with cardiac disease or using anti-arrhythmic agents
- Patients with fibromyalgia or chronic pain syndromes such as rheumatoid arthritis, osteoarthritis, or lupus.
- Daily narcotic or opiate use for greater than the 2 months prior to enrollment in the study.
Data sourced from ClinicalTrials.gov (NCT03500211). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.